Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC8 | Q9BY41 | 8/20 | 0.42 |
| ▸ | HDAC6 | Q9UBN7 | 8/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 6/20 | 0.42 |
| ▸ | GRM5 | P41594 | 1/20 | 0.39 |
| ▸ | MT-CO1 | P00395 | 1/20 | 0.39 |
| ▸ | MT-CO2 | P00403 | 1/20 | 0.39 |
| ▸ | PSEN1 | P49768 | 2/20 | 0.35 |
| ▸ | PSEN2 | P49810 | 2/20 | 0.35 |
| ▸ | APH1B | Q8WW43 | 2/20 | 0.35 |
| ▸ | NCSTN | Q92542 | 2/20 | 0.35 |
| ▸ | APH1A | Q96BI3 | 2/20 | 0.35 |
| ▸ | PSENEN | Q9NZ42 | 2/20 | 0.35 |
| ▸ | F10 | P00742 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11303328 | 0.90 | HDAC8 (0.37) | HDAC8HDAC6HDAC1PSEN1PSEN2 | |
| SCHEMBL11301754 | 0.89 | PSEN1 (0.42) | HDAC8HDAC6HDAC1PSEN1PSEN2 | |
| SCHEMBL11302647 | 0.87 | HDAC6 (0.43) | HDAC8HDAC6HDAC1GRM5 | |
| SCHEMBL11296595 | 0.87 | HDAC6 (0.42) | HDAC8HDAC6HDAC1PSEN1PSEN2 | |
| SCHEMBL11303268 | 0.86 | ABL1 (0.37) | HDAC8HDAC6HDAC1PSEN1PSEN2 | |
| SCHEMBL11296532 | 0.86 | SLC6A3 (0.40) | GRM5 | |
| SCHEMBL11296174 | 0.86 | HDAC8 (0.44) | HDAC8HDAC6HDAC1 | |
| SCHEMBL11304382 | 0.85 | HDAC8 (0.38) | HDAC8HDAC6GRM5F10 | |
| SCHEMBL11297505 | 0.85 | HDAC8 (0.37) | HDAC8HDAC6HDAC1GRM5PSEN1 | |
| SCHEMBL11300698 | 0.85 | PSEN1 (0.36) | HDAC8HDAC6HDAC1PSEN1PSEN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2665706-A1 | NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER | F.HOFFMANN-LA ROCHE AG (CH) | 2013-11-27 | — | — | EP | disclosed |
| WO-2012098132-A1 | NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER | F. HOFFMANN-LA ROCHE AG (CH) | 2012-07-26 | — | — | WO | disclosed |